Sanofi India Hits 52-Week Low, Trading at Rs 33.05

Sanofi India has reached a significant milestone by touching its 52-week low on November 11, 2025, with a new low price recorded at Rs 33.05. This development comes amid a challenging period for the stock, which has seen a consecutive decline over the past five days, resulting in a total drop of 4.15%.
In terms of performance metrics, Sanofi India has experienced a notable decline of 27.85% over the past year, contrasting sharply with the Sensex's positive performance of 5.50% during the same timeframe. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trend.

Despite these challenges, Sanofi India maintains a high dividend yield of 4.17%, reflecting its commitment to returning value to shareholders. The company also boasts a strong management efficiency, with a return on equity (ROE) of 35.83% and a low debt-to-equity ratio, positioning it favorably in terms of financial stability. However, the long-term growth outlook remains subdued, with net sales and operating profit showing negative growth rates over the past five years.